Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone and Dexmedetomidine for Preventing Nausea and Vomiting After Cesarean Section
IRCT20240221061070N10Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Dec 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dexamethasone and dexmedetomidine in postoperative nausea and vomiting (PONV), sponsored by Isfahan University of Medical Sciences. Started Dec 2025; status: completed.
02
Drugs
dexamethasonedexmedetomidine
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on IRCT20240221061070N10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240221061070N10.